top of page

2024 China Surgical Robotics Market Summary Report

December 5, 2025

2024 China Surgical Robotics Market Summary Report

December 5, 2025

Executive Summary

In January 2025, MedChina conducted a comprehensive review of China’s surgical robotics market based on weekly procurement records and partial sales data provided by several manufacturers. This report summarizes the minimum confirmed sales and installations of surgical robotic systems in 2024, covering both systems sold in China and overseas orders of China-based companies.


By publishing this dataset in English, MedChina aims to offer global stakeholders a transparent, independent reference for understanding the scale, performance, and global footprint of surgical robotics companies originating from China.


A total of at least 313 surgical robotic systems were sold or installed in 2024.


Methodology & Notes:

This annual review integrates:

  • Public procurement records from national and provincial tender platforms

  • Verified or partially verified sales data from manufacturers

  • Overseas orders publicly announced or confirmed by companies


Readers should note:

  1. The dataset is a conservative estimate. Some information is not publicly accessible, including:

    • Bundled public procurement packages

    • Purchases by military hospitals

    • Private hospital purchases

    • Government-funded special programs

    • Overseas sales not publicly disclosed

  2. Procurement ≠ order ≠ installation. Due to the long sales cycle of surgical robots, numbers may vary slightly across these stages.

  3. Scope limitation. Only surgical robotic systems are counted. Navigation systems, Class II devices, and equipment without verifiable regulatory registration are excluded.


2024 Market Overview

Total surgical robotic systems tracked in 2024: 313 units (minimum confirmed)


  1. Laparoscopic Surgical Robots (157 units)

Company

Units

Notes

Intuitive Surgical – da Vinci

58 (China)

Edge Medical

21 (China) + 5 (overseas orders)

MicroPort – Toumai®

18 (China) + 21 (overseas orders)

Cumulative tender wins in China: 33

Sagebot Intelligent Medical

15 (China) + 11 (overseas orders)

SHURUI / Surgerii Robotics

8 (China)

Total: 157 units


  1. Orthopedic Surgical Robots (94 units)

Company

Units

MicroPort – SkyWalker™

1 (China) / 25 (global orders)

TINAVI Medical

22 (China)

Tuodao Medical

16 (China)

Stryker

8 (China)

Medtronic

6 (China)

Jianjia Robot

5 (China)

Yuanhua Robotics

4 (China)

HURWA

2 (China)

ZOEZEN ROBOT

2 (China)

Zimmer Biomet

2 (China)

LANCET Robotics

1 (China)

Visual MedTech

1 (China)

Total: 94 units


  1. Dental Surgical Robots (29 units)

Company

Units

Yakebot

15 public hospital tenders + 10 private clinic orders (China)

Jianjia Robot

2 (China)

Remebot

2 (China)

Total: 29 units


  1. Neurosurgical Robots (20 units)

Company

Units

Remebot

11 (China)

Sinovation

8 (China)

Brainlab

1 (China)

Total: 20 units


  1. Vascular Interventional Robots (8 units)

Company

Units

MicroPort – R-ONE

8 (China)

Total: 8 units


  1. Natural Orifice Endoluminal Robots (4 units)

Company / Product

Units

Intuitive Surgical – Ion

4 (China)

Total: 4 units


  1. Percutaneous Surgical Robots (1 unit)

Company

Units

TrueHealth

1 (China)

Total: 1 unit


Conclusion

Across all categories, at least 313 surgical robotic systems were sold or installed in 2024. Although actual market activity exceeds these confirmed figures, this report provides the most consolidated and independently compiled reference available to international readers seeking visibility into China’s rapidly evolving surgical robotics landscape.



MedChina, January 17, 2025

medchina logo

About Us

Beijing-based healthcare media covering China's medical technology sectors including surgical robotics, cardiovascular/orthopedic/ophthalmic devices, medical imaging, and aesthetic medicine. Through news reporting and industry events, we connect Chinese and global professionals.

© 2025 by MedChina. Powered and secured by Wix

bottom of page